RNL 2022: Psoriatic Arthritis Advances

Psoriatic Arthritis Advances Faculty Panel: Q&AПодробнее

New Treatments for Psoriasis and Psoriatic ArthritisПодробнее

Drug Targeting in Psoriatic Arthritis - Bruce Kirkham, MDПодробнее

Juvenile Psoriatic Arthritis (JPsA) and Juvenile Spondyloarthritis (JSpA)Подробнее

Tuesday Night Rheumatology: Psoriatic Arthritis Replay from RNL 2024Подробнее

Advances in Psoriatic Arthritis and SpondyloarthropathyПодробнее

Tuesday Night Rheumatology - Psoriatic Arthritis Highlights from RNL 2021Подробнее

Update in Treatment of Psoriatic ArthritisПодробнее

RNL 2022: Spondyloarthritis SpectrumПодробнее

Link Between Psoriasis + DEPRESSION #shortsПодробнее

QD178 - Your Psoriatic Questions from RNL2022Подробнее

Dr. Christopher Ritchlin - Advances in Psoriatic ArthritisПодробнее

EULAR 2022 - New Data Show Durable Efficacy for Janssen’s TREMFYA Across Psoriatic Arthritis DomaiПодробнее

Advances in Psoriatic Arthritis - Ep. 10Подробнее

CAPES: Spondyloarthritis and Psoriatic Arthritis Treatment Update Patient WebinarПодробнее

3/3/2023: The Road to Prevention of Psoriatic ArthritisПодробнее

RNL 2022: RA - Improving Future TherapyПодробнее

RNL 2021 - Advancing Treatment in Psoriatic Arthritis - Dr. Eric RudermanПодробнее

RNL 2022: Hot Topics in RheumatologyПодробнее